Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Efficient gene targeting in mouse embryonic stem cells

N S Templeton1, D D Roberts, B Safer

  • 1ABL-Basic Research Program, NCI-FCRDC, Frederick, MD 21702-1201, USA.

Gene Therapy
|July 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dietary fat overcomes the protective activity of thrombospondin-1 signaling in the Apc(Min/+) model of colon cancer.

Oncogenesis·2016
Same author

Identification and removal of colanic acid from plasmid DNA preparations: implications for gene therapy.

Gene therapy·2010
Same author

A combinatorial approach for targeted delivery using small molecules and reversible masking to bypass nonspecific uptake in vivo.

Gene therapy·2010
Same author

Dithiolethione compounds inhibit Akt signaling in human breast and lung cancer cells by increasing PP2A activity.

Oncogene·2009
Same author

Thrombospondin-1: a physiological regulator of nitric oxide signaling.

Cellular and molecular life sciences : CMLS·2008
Same author

Thrombospondins: from structure to therapeutics.

Cellular and molecular life sciences : CMLS·2008
Same journal

Improving the precision of AAV lung gene therapy for SP-B deficiency using computationally derived lung-specific promoters.

Gene therapy·2026
Same journal

Recent advancements in improving cross-species applicability of bioengineered AAV capsids.

Gene therapy·2026
Same journal

Assessment of F/HN-pseudotyped lentiviral vector following intravenous delivery to mice.

Gene therapy·2026
Same journal

Applications of genome editing technologies in the treatment of human diseases.

Gene therapy·2026
Same journal

High resolution ES-DMA quantifies AAV capsid DNA content by electrical mobility to mass correlation.

Gene therapy·2026
Same journal

AAV8-mediated mouse/human PROC expression rescues thrombophilia in hereditary protein C-deficient mice.

Gene therapy·2026
See all related articles

Researchers developed a novel method to significantly enhance gene targeting efficiency in mouse embryonic stem cells (ES cells), achieving a 100-fold improvement. This breakthrough allows for gene correction without the need for selectable markers, streamlining genetic engineering processes.

Area of Science:

  • Molecular Biology
  • Stem Cell Biology
  • Genetic Engineering

Background:

  • Homologous recombination is crucial for gene correction in mouse embryonic stem cells (ES cells).
  • Current methods achieve low absolute frequencies of homologous recombination (10^-5 to 10^-6).
  • Improving gene targeting efficiency is essential for advancing genetic engineering techniques.

Purpose of the Study:

  • To develop and optimize methods for significantly improving gene correction efficiency in mouse ES cells.
  • To achieve a high absolute frequency of homologous recombination for efficient gene targeting.
  • To enable gene targeting without the use of selectable markers.

Main Methods:

  • Utilized micro-electroporation chambers and a modified electroporation procedure to minimize cell death.

Related Experiment Videos

  • Optimized plating density and cell growth conditions for electroporated ES cells.
  • Investigated co-plating with non-electroporated cells and selective media to enhance colony formation and targeting frequency.
  • Main Results:

    • Achieved an unprecedented absolute frequency of homologous recombination of 10^-1 in mouse ES cells, a 100-fold improvement.
    • Demonstrated that optimal plating density and co-plating strategies significantly increase the recovery of targeted cells.
    • Successfully performed gene targeting without the need for selectable markers due to the high targeting frequency.

    Conclusions:

    • The developed methods dramatically enhance gene targeting efficiency in mouse ES cells.
    • This high-efficiency protocol facilitates gene correction and genetic engineering without selectable markers.
    • Optimized cell culture and electroporation techniques are critical for maximizing homologous recombination rates.